NIH-funded research R01 grant

Understanding how cells adapt their growth cycles

Official title: Molecular basis of cell-cycle plasticity and robustness

Funded at University of Colorado · NIH-10981127 · Data updated 2026-11-12

This study is looking at how cancer cells can change their growth and division patterns when faced with different treatments, and it aims to find new ways to overcome drug resistance, which could help improve cancer therapies for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado
NIH-funded
Lab location1 site (Boulder, UNITED STATES)
Project startSeptember 1, 2024
Project endAugust 31, 2028
Funding year2024
Award (this year)$383,891
NIH project number1R01GM152642-01A1
Project IDNIH-10981127 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with cancers that are known to develop resistance to current therapies.

Less likely to help

Patients with non-cancerous conditions or those whose cancers do not exhibit cell-cycle plasticity may not benefit from this research.

What this research studies

This research investigates the flexibility of the mammalian cell cycle, which is traditionally viewed as a fixed process. It explores how cells can adapt their growth and division pathways in response to different conditions, particularly in the context of cancer treatment. By examining the role of Cyclin-Dependent Kinases (CDKs) and their inhibitors, the research aims to uncover new strategies to combat drug resistance in cancer therapies. Patients may benefit from insights that could lead to more effective treatments for cancers that exploit these adaptive mechanisms.

Why it matters

Potential benefit: If successful, this research could lead to improved cancer treatments that overcome drug resistance.

How similar studies have gone: Previous research has shown that understanding cell cycle dynamics can lead to significant advancements in cancer treatment, suggesting this approach has potential for success.

Where this research is happening

  • University of Colorado
    Boulder, United States
    Active

Researchers

  • Principal investigator: Spencer, Sabrina Leigh — University of Colorado
  • Study coordinator: Spencer, Sabrina Leigh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.